All Pharmaceutical industry articles – Page 4
View all stories with this category.
-
NewsBig costs, no benefits to UK’s replacement for EU chemical regulation
Industry warns small volume chemicals could no longer be sold in the UK
-
Business
UK government sets out antimicrobial resistance plan
Aims to cut antibiotic use and explore financial incentives for pharmaceutical companies
-
Business
Battling the US opioid epidemic
Adapt pharma’s naloxone nasal spray makes treating overdoses easier
-
Research
Patent-busting AI tool navigates around protected drug pathways
Organic retrosynthesis software can identify key bonds involved in patented reactions to find alternative pathways
-
Opinion
What are the rate-limiting steps in drug discovery?
Getting more drugs to market is not just a chemistry problem
-
Business
Pfizer to close two manufacturing plants in India
Closures will lead to the loss of 1700 jobs – almost 6% of the pharma giant’s manufacturing workforce
-
Business
Chinese plant closures disrupt supply chains
Environmental clampdown knocks out major suppliers of some ingredients
-
Business
Bristol-Myers Squibb to buy Celgene for $74 billion
Deal boosts BMS’s cancer and immunology pipeline with 5 drugs in late stage clinical trials
-
Sponsored
Strength through diversity
Why people should be at the heart of a forward-thinking contract research organisation
-
Business
GSK and Pfizer joint venture creates new consumer healthcare giant
Enlarged GSK consumer health will have largest market share of any firm and be a leader in key countries
-
-
Opinion
How science shapes our psychology
We learn to embrace the unexpected, follow evidence over opinion and accept that most experiments fail
-
Business
Pharmaceuticals roundup 2018
Merger deals, product approvals and infrastructure changes have been overshadowed by political uncertainty, in Europe and around the world
-
Business
Bayer to cut 12000 jobs
As it integrates Monsanto businesses, Bayer will eliminate around 10% of its global workforce
-
Business
Sartan drug contamination brings cancer uncertainty
Levels of nitrosamines and other carcinogens in affected tablets of valsartan and related drugs similar to smoking 20 cigarettes a day
-
Business
Sensing the sweet spot
Ziylo’s selective glucose-binding molecule could open doors to smart insulin for diabetes
-
Opinion
Pushing the limits of patent protection
Some methods of extending exclusivity rights raise legal and ethical questions
-
Business
Breaking the silence of RNA interference drugs
A wave of treatments is set to follow the first approval of an RNAi therapy
-
Review
Bitter Pills: The Global War on Counterfeit Drugs
Muhammad Zaman’s book gives an account of the challenges facing drug regulators worldwide
-
Business
Transforming PET imaging with silicon
Fuzionaire Diagnostics can add Si–18F radiolabels to a variety of molecules quickly, easily and cheaply
